These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Letter: Antidotes for drug overdose. Mendelson G Anaesth Intensive Care; 1975 Aug; 3(3):268-9. PubMed ID: 1166956 [No Abstract] [Full Text] [Related]
6. [Delirium due to orphrnadine chloride treated with physostigmine salicylate]. Klauber PV Ugeskr Laeger; 1976 Jan; 138(4):225-6. PubMed ID: 1251484 [No Abstract] [Full Text] [Related]
7. The influence of physostigmine on respiratory and circulatory changes caused by overdoses of orphenadrine or imipramine in the rat. Zandberg P; Sangster B Acta Pharmacol Toxicol (Copenh); 1982 Mar; 50(3):185-95. PubMed ID: 7090842 [TBL] [Abstract][Full Text] [Related]
8. The influence of orphenadrine HCl in overdose alone and in combination with droperidol on respiration and circulation in the rat. Sangster B; Nieuwland G; Zimmerman AN; Van Heijst AN Toxicol Eur Res; 1979 Mar; 2(2):93-7. PubMed ID: 505448 [TBL] [Abstract][Full Text] [Related]
9. Orphenadrine poisoning in a child: clinical and analytical data. Van Herreweghe I; Mertens K; Maes V; Ramet J Intensive Care Med; 1999 Oct; 25(10):1134-6. PubMed ID: 10551971 [TBL] [Abstract][Full Text] [Related]
11. Orphenadrine poisoning and review of physostigmine. Clark RF J Emerg Med; 1993; 11(1):97. PubMed ID: 8445195 [No Abstract] [Full Text] [Related]
12. The use of physostigmine in the management of gamma-hydroxybutyrate overdose. Mullins ME; Dribben W Ann Emerg Med; 2001 Sep; 38(3):347-8. PubMed ID: 11547795 [No Abstract] [Full Text] [Related]
13. [Clinical pharmacology of anticholinergic antiparkinson agents. A review with emphasis on acute toxicity]. Gjerden P; Slørdal L Tidsskr Nor Laegeforen; 1998 Jan; 118(1):53-5. PubMed ID: 9481912 [TBL] [Abstract][Full Text] [Related]
14. Determination of orphenadrine plasma levels using HPLC with diode array detection and a novel solid-phase extraction procedure in psychiatric patients. Saracino MA; Petio C; Vitali M; Franchini L; Raggi MA J Pharm Biomed Anal; 2009 Oct; 50(3):501-6. PubMed ID: 19524386 [TBL] [Abstract][Full Text] [Related]
15. Deaths after overdoses of orphenadrine. Millar WM Lancet; 1977 Sep; 2(8037):566. PubMed ID: 95780 [No Abstract] [Full Text] [Related]
16. Cardiotoxicity from orphenadrine intoxication in humans. Malizia E; Sarcinelli L; Pascarella M; Ambrosini M; Smeriglio M; Russo A Arch Toxicol Suppl; 1980; 4():425-7. PubMed ID: 6933954 [TBL] [Abstract][Full Text] [Related]
17. [Fatalities caused by anticholinergic antiparkinsonian drugs. Analysis of findings in a 11-year national material]. Gjerden P; Engelstad KS; Pettersen G; Slørdal L Tidsskr Nor Laegeforen; 1998 Jan; 118(1):42-4. PubMed ID: 9481909 [TBL] [Abstract][Full Text] [Related]
18. Forensic toxicology of some orphenadrine-related deaths. Robinson AE; Holder AT; McDowall RD; Powell R; Sattar H Forensic Sci; 1977; 9(1):53-62. PubMed ID: 838418 [TBL] [Abstract][Full Text] [Related]
19. [Acute poisoning by orphenadrine]. Elmalem J; Garnier R; Nguyen Huu Chieu R; Bismuth C; Efthymiou ML Ann Med Interne (Paris); 1985; 136(8):640-5. PubMed ID: 3833010 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic responses to physostigmine in patients with a drug overdose. Nilsson E; Meretoja OA; Neuvonen P Anesth Analg; 1983 Oct; 62(10):885-8. PubMed ID: 6614520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]